Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2007
[Construction and expression of recombinant adenovirus carrying human SHP-1 gene].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Xiao-ling, Zhao Sha, Yu Jian-bo, Huang Rui, Zhang Ying-chun, Liu Wei-ping
Аннотация
OBJECTIVE: To construct and identify recombinant adenovirus Ad-SHP1 carrying human SH2 domain-containing protein tyrosine phosphatase (SHP-1).
METHODS: Human SHP-1 cDNA from healthy volunteers' peripheral blood lymphocyte was cloned into the shuttle plasmid pAdTrack-CMV by standard procedure. The plasmid pAdTrackCMV-SHP1 was selected and then linearized by Pme I, followed by homologous recombination with bone plasmid pAdEasy-1 in BJ5183. Recombinant adenovirus Ad-SHP1 were obtained after packaged in HEK293 cells and the green fluorescence in HEK293 cells was observed. Recombinant adenovirus was confirmed with PCR and the expressed SHP-1 protein was verified with Western Blotting. Ad-SHP1 was multiplied and purified. The titer of virus was measured with fluorescent counter. Results The results of sequencing, restriction endounclease digestion and Western Blotting indicated that Ad-SHP1 was successfully constructed. The titer of Ad-SHP1 reached 1.58 x 10(10) pfu/mL.
CONCLUSION: Recombinant adenovirus Ad-SHP1 had been successfully constructed. It could express SHP-1 protein stably and effectively and this will be very helpful for the further study of the generation of extranodal NK/T cell lymphoma and the corresponding therapy.
METHODS: Human SHP-1 cDNA from healthy volunteers' peripheral blood lymphocyte was cloned into the shuttle plasmid pAdTrack-CMV by standard procedure. The plasmid pAdTrackCMV-SHP1 was selected and then linearized by Pme I, followed by homologous recombination with bone plasmid pAdEasy-1 in BJ5183. Recombinant adenovirus Ad-SHP1 were obtained after packaged in HEK293 cells and the green fluorescence in HEK293 cells was observed. Recombinant adenovirus was confirmed with PCR and the expressed SHP-1 protein was verified with Western Blotting. Ad-SHP1 was multiplied and purified. The titer of virus was measured with fluorescent counter. Results The results of sequencing, restriction endounclease digestion and Western Blotting indicated that Ad-SHP1 was successfully constructed. The titer of Ad-SHP1 reached 1.58 x 10(10) pfu/mL.
CONCLUSION: Recombinant adenovirus Ad-SHP1 had been successfully constructed. It could express SHP-1 protein stably and effectively and this will be very helpful for the further study of the generation of extranodal NK/T cell lymphoma and the corresponding therapy.